# Efficacy of Defurocumarinized Bergamot in the Treatment of Agitation in Severe Dementia Patients.

> **NCT04321889** · NA · UNKNOWN · sponsor: **S.Anna Rehabilitation Institute** · enrollment: 134 (estimated)

## Conditions studied

- Severe Dementia
- Stroke

## Interventions

- **DEVICE:** defurocumarinized bergamot loaded in a nanotechnological essential oil release system
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04321889
- **Lead sponsor:** S.Anna Rehabilitation Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2020-12-10
- **Final completion:** 2021-06-30
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2020-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321889, "Efficacy of Defurocumarinized Bergamot in the Treatment of Agitation in Severe Dementia Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04321889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*